Kelly Olino, MD, FACS
Assistant Professor of Surgery (Oncology); Leader, Skin Cancer Surgery, Melanoma Program; Clinical Director of the Smilow Melanoma Program, Yale Cancer Center; Co-Director Cutaneous Malignancy Tumor Board, Yale Cancer Center
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Kelly Olino, MD, FACS, is a doubly board -certified surgeon who provides patients with comprehensive surgical care including resection of skin and soft tissue tumors including melanoma, merkel cell carcinoma, sarcoma, and advanced cutaneous squamous cell and basal cell carcinoma, including minimally invasive techniques for metastatic disease. Dr. Olino is a past recipient of the Society for Surgical Oncology’s Clinical Investigator Award to support her research in tumor immunology. She continues this work at Yale and has been funded through the Calabresi Immune-Oncology scholar program and the Skin Cancer SPORE career enhancement program. She continues her work in translational research combining her knowledge of tumor immunology with her clinical acumen. She currently serves on the NCCN non-melanoma cutaneous malignancy committee.
Education & Training
- FellowshipThe Memorial Sloan Kettering Cancer Center (2015)
- ResidencyThe Johns Hopkins Hospital (2013)
- MDThe Johns Hopkins School of Medicine (2005)
- BSCornell University, Biological Sciences-Neurobiology (2000)
Activities
- What's Next? Treatment Choices After Anti-PD-1 AntibodyChicago, IL, United States 20222022 ASCO Annual Meeting
- Merkel Cell Carcinoma: Tumor Biology and Biomarkers.Dallas, TX, United States 2022Society of Surgical Oncology 2022 International Conference on Surgical Cancer Care
- The Changing Landscape for Merkel Cell CarcinomaVirtual due to COVID-19 2022The Johns Hopkins Department of Surgery Grand Rounds
- The Evolution in the Management of Merkel Cell Carcinoma at Yale: Past Experience and Future DirectionsNew Haven, CT. Virtual due to COVID-19 2022Yale Cancer Center Grand Rounds
- Surgical Oncology Potpourri for the ABSITEVirtual due to COVID-19 2022Connecticut Chapter of the American College of Surgeons
- Co-targeting the innate and adaptive immune systems to overcome resistance to anti-PD(L)-1Virtual due to COVID-19 2021Inter-SPORE Melanoma Meeting
- Merkel Cell Carcinoma: Evolution in management of a rare malignancy.Virtual Due to COVID 19 2020Academic Surgical Congress
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| Texas Rising Stars | Super Doctors | 2018 |
| Golden Scalpel Medical Student Teaching Award | University of Texas Medical Branch School of Medicine | 2016 |
| Society for Surgical Oncology Clinical Investigators Award | Society for Surgical Oncology Foundation | 2016 |
| Frank Coulson Resident Clinical Excellence Award | The Johns Hopkins School of Medicine | 2013 |
| Department of Surgery Medical Student Teaching Award | The Johns Hopkins School of Medicine | 2013 |
| Anthony Imbembo Resident Teaching Award | The Johns Hopkins School of Medicine | 2013 |
| Anthony Imbembo Resident Teaching Award | The Johns Hopkins School of Medicine | 2012 |
| Anthony Imbembo Resident Teaching Award | The Johns Hopkins School of Medicine | 2011 |
| Baltimore Academy of Surgery Research Award | 2009 | |
| George Zuidema Basic Science Award | The Johns Hopkins School of Medicine | 2008 |
Professional Service
| Organization | Role | Date |
|---|---|---|
| Frontiers of Immunology: Cancer Immunity and Immunotherapy | Editor | 2022 - Present |
| Society of Surgical Oncology | Program Committee member. | 2022 - Present |
| The Society for Surgical Oncology | Immunotherapy-oncology program committee | 2022 - Present |
| The Society of Surgical Oncology | Scientific Program Committee- Chair Immuno-oncology subgroup | 2022 - Present |
| National Comprehensive Cancer Network- Non-Melanoma Skin Cancer Panel | Representative of Yale Cancer Center/Smilow Cancer Hospital for national guideline development for the treatment of cutaneous skin cancers including squamous cell carcinoma, basal cell carcinoma, dermatofibrosarcoma and merkel cell carcinoma. | 2022 - Present |
| Status of Women in Medicine- Department of Surgery Liason | Liaison | 2022 - Present |
| National Comprehensive Cancer Network- Non-Melanoma Skin Cancer Guideline Panel | Creation of national guidelines for merkel cell carcinoma, cutaneous squamous cell carcinoma, basal cell carcinoma and dermatofibrosarcoma protuberans | 2022 - Present |
| Journal of Surgical Research | Editor | 2021 - Present |
| Yale New Haven Hospital Credentials Committee | Member | 2021 - Present |
| Yale Cancer Center - Smilow Clinical Council | Member | 2021 - Present |
| The Society for Immunotherapy of Cancer | Co-Chair Surgery Committee Session for 2021 National Meeting | 2021 - 2022 |
| Schwartz Cancer Center Grand Rounds Planning Committee | Committee Member | 2021 - Present |
| Cancers | Reviewer | 2021 - Present |
| The Society of Surgical Oncology | Melanoma Disease Site Working Group. Planning of education activities and guidelines for the management of cutaneous malignancies. | 2020 - 2022 |
| Yale Center for Immuno-Oncology | Symposia and seminar planning committee | 2019 - Present |
| Association for Academic Surgery | Institutional Representative for Yale Department of Surgery Membership Committee | 2019 - 2023 |
| Association for Academic Surgery | Program Committee | 2016 - Present |
| Annals of Surgical Oncology | Reviewer | 2015 - Present |
| Journal of Surgical Oncology | Reviewer | 2015 - Present |